Tirzepatide is one of the most popular peptides in the weight loss and metabolic health category. It is a dual agonist that targets both GLP-1 and GIP pathways, which is why tirzepatide is often discussed as a step beyond single-receptor GLP-1 peptides like semaglutide.
Most people looking at tirzepatide are interested in appetite control, body composition, long-term weight management, metabolic health, and longevity-focused protocols. Tirzepatide has become a major name in modern incretin research because it combines two appetite and metabolism-related signaling pathways in one peptide.
The GLP-1 activity is tied to appetite signaling, insulin response, glucagon regulation, and gastric emptying. The added GIP activity is part of what makes tirzepatide especially interesting for metabolic research, body-weight studies, and comparison work against semaglutide and retatrutide.
Progression Peptides offers tirzepatide in 10mg, 20mg, 30mg, and 60mg vial options so you can match the vial size to the protocol. The lower-strength vials are useful for conservative starts or smaller plans, while the larger tirzepatide vials make more sense for longer protocols or higher total-use planning.
Each vial is supplied as lyophilized tirzepatide powder for reconstitution with bacteriostatic water.
Reconstitution: Reconstitute with bacteriostatic water. Allow the powder to dissolve gently without shaking.
Storage: Store at -20 degrees C. Once reconstituted with bacteriostatic water, refrigerate at 2-8 degrees C and use within 30 days.
For Research Purposes Only. Not for human consumption. Not for veterinary use. Sold strictly for in vitro and laboratory research applications.
